848.2500 4.00 (0.47%)
NSE Sep 11, 2025 15:31 PM
Volume: 440.1K
 

848.25
0.47%
ICICI Securities Limited
Natco has carved out its own identity via tie-ups to tap limited but niche products pipeline including 20 Para IVs filings (FY19). As per the revised and more feasible game plan, it plans to market products via tie-ups with established players in the generic space. Till FY19, the company filed 51 ANDAs, which includes some niche FTF opportunities. Overall, the...
Natco Pharma Ltd. is trading below all available SMAs
More from Natco Pharma Ltd.
Recommended